⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4413153 | 1.00 | — | — | |
| SCHEMBL13600571 | 1.00 | — | — | |
| SCHEMBL29525585 | 1.00 | — | — | |
| SCHEMBL13607589 | 1.00 | — | — | |
| SCHEMBL14993672 | 1.00 | — | — | |
| SCHEMBL5868615 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL10515876 | 0.80 | GBA1 (0.34) | — | |
| SCHEMBL462864 | 0.79 | — | — | |
| SCHEMBL505753 | 0.79 | — | — | |
| SCHEMBL1313595 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12606561-B2 | Substituted pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitors | QURIENT CO., LTD. (KR) | 2026-04-21 | — | — | US | disclosed |
| EP-4255909-A1 | COMPOUNDS HAVING CYCLIN-DEPENDENT KINASE(CDK)-INHIBITORY FUNCTION | Qurient Co. Ltd. (KR) | 2023-10-11 | — | — | EP | disclosed |
| WO-2022117504-A1 | COMPOUNDS HAVING CYCLIN-DEPENDENT KINASE(CDK)-INHIBITORY FUNCTION | QURIENT CO., LTD. (KR) | 2022-06-09 | — | — | WO | disclosed |
| US-20220098208-A1 | PHARMACEUTICALLY ACTIVE PYRAZOLO-TRIAZINE AND/OR PYRAZOLO-PYRIMIDINE DERIVATIVES | QURIENT CO., LTD. (KR) | 2022-03-31 | — | — | US | disclosed |